Restaurant Brands New Zealand Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
The primary driver behind last 12 months revenue was the New Zealand segment contributing a total revenue of NZ$625.9m (42% ...
EurekAlert!5d
BAADesign enables the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants
Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.
1 Artificial Intelligence (AI) Stock to Buy Hand Over Fist Before It Surges by 60%, According to 1 Wall Street Analyst
Palantir just received a new Street-high price target.
New Antibody Therapy Shows Promise Against All COVID Variants – And the Future Ones Too
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
Antibody pair shows potential to defeat all SARS-CoV-2 variants
The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...
Mirage News3d
New Antibodies May Neutralize Covid-Causing Virus
The virus that causes COVID-19 has been very good at mutating to keep infecting people - so good that most antibody ...
Predicting SARS-CoV-2 variant infectivity with biophysical principles
When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...
TMCnet4d
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against LP.8.1 Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together ...